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A Population-Genetic Test of Founder Effects and Implications
for Ashkenazi Jewish Diseases
Montgomery Slatkin
Department of Integrative Biology, University of California Berkeley, Berkeley
A founder effect can account for the presence of an allele at an unusually high frequency in an isolated population
if the allele is selectively neutral and if all copies are identical by descent with a copy that either was carried by a
founder individual or arose by mutation later. Here, a statistical test of both aspects of the founder-effect hypothesis
is developed. The test is performed by a modiﬁed version of a program that implements the Slatkin-Bertorelle test
of neutrality. The test is applied to several disease-associated alleles found predominantly in Ashkenazi Jews. Despite
considerable uncertainty about the demographic history of Ashkenazi Jews and their ancestors, available genetic
data are consistent with a founder effect resulting from a severe bottleneck in population size between A.D. 1100
and A.D. 1400 and an earlier bottleneck in A.D. 75, at the beginning of the Jewish Diaspora. The relatively high
frequency of alleles causing four different lysosomal storage disorders, including Tay-Sachs disease and Gaucher
disease, can be accounted for if the disease-associated alleles are recessive in their effects on reproductive ﬁtness.
Introduction
A founder effect can result either from a true founder
event (i.e., the establishment of a new population from
individuals derived from a much larger population) or
from an extreme reduction in population size (i.e., a
bottleneck in size). In either case, alleles present in one
copy immediately after the founder event or bottleneck
may be found at a much higher frequency than they were
previously and can reach even higher frequencies be-
cause of strong genetic drift occurring while the popu-
lation is still small.
Founder effects have been used to explain the pres-
ence of high-frequency Mendelian diseases in many iso-
lated populations (Thompson andNeel 1996; Vogel and
Motulsky 1996). Even though disease-associated alleles
are probably not neutral, even slightly deleterious alleles
may increase in frequency because of founder effects.
Both the founder effect and heterozygote advantage
have been invoked to account for several disease-as-
sociated alleles in the Ashkenazi Jewish (AJ) population
(Risch 2001). The hypothesis of heterozygote advantage
is supported primarily by the fact that four of the dis-
eases—Tay-Sachs disease, Gaucher disease, mucolipi-
dosis type IV, and Niemann-Pick disease—are results of
defects in sphingolipid storage (Zlotogora et al. 1988),
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defects that are quite rare in most other populations.
This unusual concentration of lipid-storage diseases
(LSDs) suggests that selection has favored heterozygous
carriers of alleles affecting lipid metabolism and storage,
possibly because of resistance to tuberculosis (Motulsky
1995). Further support for heterozygote advantage
comes from the discovery that more than one disease-
associated allele has been found to cause LSDs in Ash-
kenazi Jews, the logic being that it is unlikely that more
than one allele at a locus would increase in frequency
only because of a founder effect (Diamond 1994; Mo-
tulsky 1995). Selection favoring heterozygous carriers
would, however, select for any alleles conferring that
advantage. Rotter and Diamond (1987) argue also that
the wide geographic range of AJ disease-associated al-
leles is evidence of heterozygote advantage.
Until the 1990s, heterozygote advantage was the fa-
vored explanation for LSDs in the AJ population. More
recently, however, the founder-effect hypothesis has
gained acceptance, because several studies have sug-
gested that disease-associated alleles are identical by de-
scent and arose relatively recently (Risch et al. 1995b;
Goldstein et al. 1999; Niell et al. 2003; Frisch et al.
2004). Risch et al. (2003) recently compiled available
data and argued that founder effects rather than het-
erozygote advantage accounted for all LSDs in the AJ
population. Risch et al. (2003) showed that there was
no difference between LSDs and non–lipid-storage dis-
eases (NLSDs) in (a) estimated allele ages, (b) numbers
of disease-associated alleles, and (c) inferred geographic
origins of alleles. They then argued that heterozygote
advantage could be ruled out for two reasons. First,
some NLSDs (idiopathic torsion dystonia [ITY], breast
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cancer type 1, and breast cancer type 2) are caused by
dominant alleles, making heterozygote advantage un-
likely. Second, similarity of the two groups can be ac-
counted for by selection only if all disease-associated
alleles beneﬁted heterozygous carriers, which is unlikely
because the NLSDs include a wide variety of disorders,
including cancers, blood diseases, and neuropathies.
Risch et al. (2003) concluded further that there is
evidence of three founder events: one 1100 generations
ago, when the Jewish population of the Middle East
was founded; the second ∼50 generations ago, when the
Jewish populations of central Europe were founded; and
the third ∼12 generations ago, when the Lithuanian
Jewish population was founded (under the assumption
of 25 years per generation).
In this article, I introduce a statistical test of the foun-
der-effect hypothesis by adding to a test of neutrality a
test of whether an allele either was present in a single
copy at the time of a hypothesized founder event or
arose by mutation afterwards. The new test is applied
to alleles causing Mendelian diseases in Ashkenazi Jews.
Although current uncertainty about the early demo-
graphic history of the AJ population will not allow a
strong conclusion to be reached, the results show that
the available genetic data for AJ disease alleles are con-
sistent with the founder-effect hypothesis if plausible
assumptions are made about early AJ population sizes.
This analysis cannot prove that there was no hetero-
zygote advantage, but it does show that selection is not
needed to account for current information about AJ
Mendelian diseases. The test also shows, however, that
alleles with frequencies 11% could not be traced to the
two recent founder events discussed by Risch et al.
(2003). For those alleles, the important founder event
was at the beginning of the Jewish Diaspora, after the
destruction of the Second Temple in A.D. 70.
Statistical Test
To test the founder-effect hypothesis, two separate tests
are needed. The ﬁrst is a test that determines whether
there is more linkage disequilibrium (LD) with a linked
marker allele than is consistent with neutrality. The neu-
trality test used here is equivalent to the one introduced
by Slatkin and Bertorelle (2001) and is similar to the
that of Thompson and Neel (1997). The test assumes
that the locus of interest is effectively diallelic, with allele
A being associated with the presence of a disease and
the alternative allele, a, representing all other variants
at this locus. The A/a locus is linked to a diallelic marker
locus with alleles M and m. The information needed for
the test is (a) the history of population sizes; (b) i, the
number of A-bearing chromosomes in a sample of n
chromosomes; (c) x, the population frequency of A; and
(d) jo, the number of A-bearing chromosomes that carry
the marker allele presumed to have been on the ancestral
A-bearing chromosome. Necessarily, , and, ifj  io
, there is perfect LD between the marker locus andj p io
A, meaning that Lewontin’s (1964) . Although′D p 1
the identiﬁcation of the ancestral marker allele can be
difﬁcult if two or more alleles are relatively common on
A-bearing chromosomes, most applications, including
all in this article, are to cases in which jo is large enough
that it is clear which allele was ancestral. In general, x
is estimated in very large population surveys and pos-
sibly in pooled clinical data, whereas i and jo are ob-
tained from smaller studies performed to either map A
or understand its history.
The test of neutrality is performed by simulating the
neutral coalescent with tips in a population ofnp i/x
variable size and then examining each node to determine
whether it has i descendents. If it does, then a mutation
on the lineage leading to that node could give rise to
an allele in i copies (see ﬁg. 1). For each such node,
called an “i-node,” the program computes the proba-
bility that j nonrecombinant chromosomes are found.
That probability is weighted by the length of the an-
cestral branch, denoted by w in ﬁgure 1, and accu-
mulated over numerous replicates to estimate , theP(j)
overall probability of ﬁnding j nonrecombinant chro-
mosomes in a sample of i A-bearing chromosomes
( ). A one-tailed test of neutrality is ob-i P(j)p 1jp0
tained by ﬁnding the net probability that , wherej  jo
jo is the observed number of nonrecombinants. If
i
Pr (j  j )p Pr (j) ! a ,o
jpjo
then the data reject neutrality of A at signiﬁcance level
a. This tests whether A is too old to be consistent with
the observed number of nonrecombinants. That is the
appropriate test if the concern is with testing for positive
selection on heterozygous carriers of a low-frequency
allele, because heterozygote advantage, with or without
lower ﬁtnesses of homozygous individuals, tends to re-
duce allele age (author’s unpublished numerical results).
If the concern is whether A is younger than expected
under neutrality, the appropriate test would be of the
other tail of . A two-tailed test could be used as well.P(j)
To test for a founder effect at a time tF in the past,
the program computes and accumulates the numbers of
lineages carrying A at tF for each i-node. As illustrated
in ﬁgure 1, the number, m, of ancestral lineages at tF
depends on tF and t2, the time of the most recent com-
mon ancestor of the intra-allelic genealogy. There are
three possibilities. If , then , and the pro-t  t m  22 F
gram records m. If , then, with prob-t  t  t w2 F 2
ability , A arose by mutation on the sin-pp (t  t )/wF 2
gle lineage present after the population was founded,
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Figure 1 Illustration of an intra-allelic genealogy for the case with . t1 is the age of the allele A, t2 is the time of the most recent commonip 4
ancestor (MRCA) of copies of A in the sample, and w is the length of branch on which A arose by mutation.
and, with probability , it arose before the popu-1 p
lation was founded and was present in one lineage at
tF. In the latter case, the program records that mp 1
weighted by . In the former case, the program1 p
records that (meaning that the allele arose bymp 0
mutation after the population was founded) weighted
by p. If , the program records that .t w  t mp 02 F
The outcome for each i-node analyzed is weighted both
by w—because that is the time during which A could
have arisen by mutation—and by . By averagingP(j )o
over a large number of replicates, the program estimates
Fm, the probability that lineages carrying Amp 0… i
were present at tF.
The data are consistent with the founder effect if
or 1. A high probability of two or more foundingmp 0
lineages is inconsistent with the founder-effect hypoth-
esis, because it implies that the allele was present at a
substantial frequency at the time the population was
founded. In the results, the probability that ormp 0
1, , is reported. If ,Pr (m  1)p F  F Pr (m  1) ! a0 1
then a founder event at tF is rejected with probability
a.
In addition to estimating the number of lineages at
the time of population founding, the program computes
the posterior distribution of age. The posterior distri-
bution takes account of the allele frequency, the history
of population sizes, and the extent of LDwith the linked
marker. From the posterior distribution, averages of
and and the associated 95% credible sets are¯ ¯t t1 2
estimated.
The program allows for arbitrary demographic his-
tories. The current effective population size, , as wellNe,0
as population sizes at times ,N ,… ,N T ,T ,… ,Te,1 e,K 1 2 K
are speciﬁed, and the population is assumed to grow
or decline exponentially at rate r p log (N /N )/k e,k1 e,k
between Tk and , where . The(T  T ) T T p 0k1 k k1 0
growth rate before Tk must also be speciﬁed.
Copies of this computer program are freely available
at the Slatkin Laboratory Genetics Software Web site.
Applications to AJ Diseases
History of AJ Population Sizes
To apply the founder-effect test to AJ diseases, esti-
mates of past effective population sizes are needed. At
present, Ashkenazi Jews comprise ∼80% of the 13–14
million Jews in the world, with most living in the United
States and Israel (Motulsky 1995). Population sizes, es-
pecially before A.D. 1500, are not known accurately, and
the historical record allows only rough estimates to be
made.
Ashkenazi Jews are recognized as forming distinct
branch of Judaism in the 13th and 14th centuries in
present-day Poland, Lithuania, Belarus, the Ukraine, and
Russia (Mourant et al. 1978). The ancestors of Ashke-
nazi Jews descended largely from Jewish populations in
present-day Germany (Weinryb 1972). Before the be-
ginning of the Crusades in A.D. 1096, Jewish populations
in Germany, France, and England had grown and thrived
and are estimated to have numbered at least 100,000
individuals (Engleman 1960; Risch 2001). With the Cru-
sades began a long period of attacks on Jews and the
wholesale destruction of Jewish communities, culminat-
ing with their expulsion from present-day England,
France, and Germany by A.D. ∼1300. Jewish population
sizes declined further in A.D. 1347 and 1348 because of
the Black Death, during which mortality rates are esti-
Slatkin: Test of the Founder-Effect Hypothesis 285
Table 1
Population Sizes of Ashkenazi Jews
and Their Ancestors Assumed in
the Simulation Program
Year (A.D.) ta NT
b
50 78 1,000,000c
70 77.2 N0
d
1096 36.16 150,000
1348 26.08 N1
e
1500 20 15,000f
1648 14.08 200,000f
1667 13.32 160,000f
1765 9.4 750,000f
1900 4 6,000,000f
2000 0 10,500,000g
a Generations before A.D. 2000,
under the assumption of 25 years per
generation.
b The effective population size
was assumed to be 1/3 of these sizes.
c Based on ﬁgure 1 of Barnavi
(1992).
d Allowed to vary; values of 150,
600, and 3,000 were used.
e Allowed to vary; values of 600,
3,000, and 6,000 were used.
f From Risch et al. (1995a).
g From Motulsky (1995).
mated to have been as high as 50%; further mortality
resulted from attacks stemming from the belief that Jews
were responsible for the Black Death in non-Jewish com-
munities (Fraikor 1977).
By A.D. 1500, the AJ population size in eastern Europe
is estimated to have been 10,000–20,000. There fol-
lowed a period of sustained population growth at a rate
of ∼40% per generation until A.D. 1900, interrupted
only by the Cossack massacres in 1648, which resulted
in the death of ∼25% of the AJ population (Weinryb
1972; Risch et al. 1995a). To account for all available
information in the context of a relatively simple model,
I assumed the population sizes given in table 1. The
population size in A.D. 2000 is based on Motulsky’s
(1995) estimate. Sizes from A.D. 1500 to 1900 are from
Risch (1995a). The size in A.D. 1096 is based on esti-
mates of Engleman (1960) and Risch (2001). The size
assumed at A.D. 70 (1,000,000) is a conservative esti-
mate based on information presented by Barnavi (1992).
The actual size and rate of exponential growth assumed
before A.D. 70 ( per generation) are not impor-rp 0.1
tant for considering later founder events. Alleles that
arose well before A.D. 70 and that were carried by several
individuals ancestral to the AJ population in A.D. 70
were probably present at relatively high frequencies in
the Jewish population as a whole and would therefore
likely be present in other modern Jewish populations as
well. To be restricted to Ashkenazi Jews, alleles had to
have been carried by a single founder chromosome or
have arisen by mutation after A.D. 70.
There were at least two important bottlenecks in pop-
ulation size that could have led to a founder effect. The
ﬁrst is at the beginning of the Diaspora in A.D. 70. Al-
though the Jewish population in present-day Israel and
surrounding countries was large before A.D. 70, only
small numbers made their way to the areas in western
Europe in which ancestors of Ashkenazi Jews resided
until the end of the 11th century. Historical records pro-
vide no information about the size of the founder group
or groups. I used a range of values (150, 600, and 3,000)
of N0, the assumed size in A.D. 70, to model founder
events of different intensities. Another potential founder
event occurred because of the persecutions during the
Crusades and the mortality associated with the Black
Death. I used a range of values of N1 in 1348 (600,
3,000, and 6,000) as the population size after the Black
Death.
The intensity of genetic drift is determined by the ef-
fective population size, not the census size. With fertility
and mortality rates typical of humans, the effective size
is ∼1/3 the census size (Hill 1972). Ashkenazi Jews and
their ancestors never comprised a randomly mating pop-
ulation but were instead dispersed over a wide geo-
graphic area. However, there was sufﬁcient movement
among AJ subpopulations that little genetic substructure
developed (Risch 2001; Risch et al. 2003). In general,
population subdivision increases effective population
size, but, unless dispersal is greatly restricted, the in-
crease is minor (Nordborg and Krone 2002).
A potential complicating factor in relating census to
effective population size is that fertility in AJ populations
was not evenly distributed among social and economic
classes (Motulsky 1979; Risch et al. 1995a, 1995b).
Wealthier and better-educated families had more off-
spring. Risch et al. (1995a, 1995b) have argued that this
social stratiﬁcation led to greatly reduced effective size
and created the opportunity for extreme founder effects.
This argument was challenged by Zoossmann-Diskin
(1995), who noted that, although differences in fertility
among social classes existed in AJ populations, the vast
majority of individuals were in the lower social classes,
so much of the high rate of population growth had to
be attributable to them. It seems difﬁcult to account for
a population growth rate of ∼40% per generation with
fertility excess only in wealthy and educated families.
Gaucher Disease
Type I Gaucher disease (MIM #230800) is a recessive
nonlethal disorder caused by mutations at the glucocer-
ebrosidase (GBA) locus on chromosome 1q21. The most
common causative allele in the AJ population is N370S
(also denoted as 1226G). Beutler et al. (1993) estimated
the frequency of N370S in the AJ population to be
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Table 2
Results of Analyzing Data for N370S at GBA and the Linked Marker
Locus D1S2464
POPULATION
SIZEa
Pr (j  j )o
bt¯2
Pr( )m  1
When
t p 26F
Pr( )m  1
When
t p 77.2FN0 N1
150 600 .72 104 (26, 184) 0 .95
150 3,000 .73 113 (55, 188) 0 .95
150 6,000 .75 111 (61, 187) 0 .95
600 600 .66 110 (26, 186) 0 .81
600 3,000 .64 116 (64, 199) 0 .75
600 6,000 .65 118 (65, 197) 0 .74
3,000 600 .59 111 (26, 190) 0 .40
3,000 3,000 .34 143 (67, 188) 0 .10
3,000 6,000 .31 147 (74, 192) 0 .05
NOTE.—Results for each combination of N0 and N1 are based on
weighted averages of 10,000 replicates. Genetic parameters are xp
, , , , and ..032 ip 268 j p 163 p p .205 vp .007o N
a N0 is the assumed population size in A.D. 70 ( ), and N1 istp 77.2
the assumed size in A.D. 1648 ( ).tp 26.08
b Numbers in parentheses are the bounds of the 95% credible set
based on the posterior distribution of t2.
. Diaz et al. (2000) found extensive LD0.032 0.004
between N370S and several closely linked marker loci.
I will present the results from the analysis of one marker
locus, D1S2464, in detail and brieﬂy summarize the re-
sults for two others. In terms of the notation here, the
genetic data for D1S2624 (with allele 5 ancestral) are
as follows: , , and pN, the frequency ofip 268 j p 163o
the ancestral marker on chromosomes not carrying the
disease allele, is 0.205 (table 3 of Diaz et al. 2000).
The value of v, the recombination rate, is not known
precisely. Values used by Diaz et al. (2000) appear to be
somewhat too large. For D1S2624, Diaz et al. (2000
[their table 4]) reported values ranging from 0.009 to
0.036, with a median of 0.015. On the basis of the July
2003 build of the human genome (available at the UCSC
Human Genome Browser Web site), D1S2624 is ∼1.4
Mb from GBA, and, according to the TSC SNP Linkage
Map (Matise et al. 2003; TSC SNP Linkage Map Web
site), the average recombination rate in this region is
∼0.5 cM/Mb, suggesting that is a bettervp 0.007
estimate.
For all combinations of demographic parameter val-
ues considered, neutrality could not be rejected, but a
recent founder event ( , A.D. 1350) is rejected int p 26F
all cases (table 2). For all combinations of N0 and N1,
numerous lineages carrying N370S were present at that
time (ﬁg. 2). In contrast, a founder event in A.D. 70
( ) was possible for all combinations of N0 andt p 77.2F
N1, although it was increasingly unlikely if neither N0
nor N1 was !3,000 (table 2). Similar results were ob-
tained with .vp 0.014
These results also show that it is difﬁcult to estimate
the age of N370S with any conﬁdence. Table 2 reports
the expected time of the most recent common ancestor,
, and the 95% credible set, both based on the posteriort¯2
distribution. The time t2, called the “coalescence time”
by Risch et al. (2003), differs from t1, the time at which
the allele arose by mutation (see ﬁg. 1).
Similar results are found using two other marker loci.
For D1S1600 (with allele 2 ancestral), ,ip 258 j po
, and . D1S1600 is ∼2.6 Mb from GBA,124 p p 0.067N
indicating . For no combination of N0 and N1vp 0.013
was neutrality rejected, and a founder event at t pF
was possible under the same conditions as indicated77.2
by D1S2464. Similar results were obtained forD1S1595,
considered by both Diaz et al. (2000) and Colombo
(2000).
The other disease-associated mutation in AJ popula-
tions is 84GG, which has a frequency of ∼0.002 (Beutler
et al. 1993). By use of the marker locus D1S2464 with
allele 4 ancestral, , , and (Diazip 32 j p 29 p p 0.373o N
et al. 2000). Neutrality was not rejected for any com-
bination of N0 and N1. The difference from the results
for N370S is that, for , the data are consistentN p 6001
with a founder event in A.D. 1348. Because 84GG is
found at a much lower frequency than N370S, it could
have attained its current frequency under drift alone if
it arose more recently.
Mucolipidosis Type IV
Mucolipidosis type IV (MLIV [MIM #252650]) is an
LSD caused by mutations at the MCOLN1 locus on
chromosome 19p13.2-13.3. The most common disease-
associated mutation in Ashkenazi Jews is an ArG tran-
sition in the acceptor spice site of the third intron (IVS3-
1ArG) (Bargal et al. 2000). Slaugenhaupt et al. (1999)
provided haplotype data for several linked marker loci.
Here, I use the marker D19S406, which is ∼180 kb from
MCOLN1. In this genomic region, the sex-averaged re-
combination rate is ∼2.5 cM/Mb (Matise et al. 2003),
indicating . From ﬁgure 2 of Slaugenhauptvp 0.0045
et al. (1999), , , and . Slau-ip 39 j p 38 xp 0.0036o
genhaupt et al. (1999) did not genotype chromosomes
not carrying IVS3-1ArG in the AJ population (S. Slau-
genhaupt, personal communication), so I used a range
of values of pN (0.1, 0.3, and 0.5). For all combinations
of parameter values, neutrality was not rejected, and a
founder event at A.D. 1348 was possible.
Adenomatous Polyposis Coli (APC)
The APC locus (MIM #175100) has an allele, I1307K
(a TrA transition at nucleotide position 3920), that in-
creases the relative risk of colorectal cancer by a factor
of 1.5–2 (Niell et al. 2003). This allele presents an un-
usual opportunity to test the founder-effect hypothesis,
because it has a high frequency in the AJ population,
, and it has a frequency 10.01 in Sephardi Jews.xp 0.06
Figure 2 Estimated posterior probability distributions of the number of ancestral lineages, m, carrying N370S at GBA (which causes Gaucher
disease) for the nine combinations of N0 (the population size at A.D. 70) and N1 (the population size at A.D. 1348) and two different hypothesized
times of founder events (A.D. 75 and 1350).
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Table 3
Results of Analyzing Data for I1307K at APC and the Linked Marker Locus D5S135
POPULATION
SIZEa RESULTS WHEN vp .0046 RESULTS WHEN vp .0023
N0 N1 Pr (j  j )o
Pr (m  1)
When t p 26F
Pr (m  1)
When t p 77.2F m¯ Pr (j  j )o
Pr (m  1)
When t p 26F
Pr (m  1)
When t p 77.2F m¯
150 600 .09 0 .93 .99 .44 0 .92 1.04
150 3,000 .03 0 .91 1.04 .28 0 .89 1.09
150 6,000 .02 0 .92 1.04 .25 0 .89 1.09
600 600 .08 0 .74 1.4 .41 0 .63 1.7
600 3,000 .02 0 .61 1.9 .23 0 .49 2.4
600 6,000 .01 0 .51 2.1 .18 0 .44 2.6
3,000 600 .05 0 .34 3.4 .29 0 .19 4.7
3,000 3,000 .004 0 0 9.1 .10 0 .007 10.5
3,000 6,000 .001 0 0 10.8 .07 0 0 12.1
NOTE.—Results for each combination of N0 and N1 are based on weighted averages of 10,000 replicates. Genetic parameters
are , , , and .xp 0.06 ip 87 j p 83 p p 0.343o N
a N0 is the assumed population size in A.D. 70 ( ), and N1 is the assumed size in A.D. 1648 ( ).tp 77.2 tp 26.08
Niell et al. (2003) examined several closely linked
marker loci and concluded from the application of the
Slatkin-Bertorelle (2001) neutrality test that their data
did not reject neutrality. That conclusion is conﬁrmed
for the more elaborate demographic model used here.
In this case, to be consistent with the presence of this
allele in the Sephardim at a signiﬁcant frequency, a foun-
der effect in the AJ population should be unlikely.
Results from the analysis of one of the linkedmarkers,
D5S135, are shown in table 3. The genetic parameters
are , , and . Two values of vip 87 j p 83 p p 0.343o N
were used. The ﬁrst, , is based on the Ko-vp 0.0046
sambi map function calculation, and the second is 1/2
that value, which is slightly larger than the smallest re-
combination rate reported in the literature (based on
table 5 of Niell et al. [2003]). Neutrality is not rejected
in all cases with the smaller v, but it was rejected in some
cases with the larger v.
Table 3 shows that a founder event in A.D. 70 is likely
for the smallest assumed population size, , but,N p 1500
even so, there is an ∼10% chance that two or more
lineages carried I1307K. For and 600,N p 1500
though, the inferred average number of lineages at A.D.
75 is small, suggesting that the allele had a low frequency
before the founder event. Only if is the av-N p 3,0000
erage higher.
These results, combined with those for N370S for
Gaucher disease, weakly constrain the possible demo-
graphic histories consistent with both data sets. N370S
is rare in other Jewish populations and was probably
introduced to them by later admixture with Ashkenazi
Jews (Risch 2001). On the basis of table 2, data for
N370S are consistent with the founder-effect hypothesis
for any combination of N0 and N1, but a founder effect
is least likely if and or 6,000.N p 3,000 N p 3,0000 1
If I1307K at APC is present in Sephardi Jews because
it originated before A.D. 70 and was carried by Sephardi
ancestors, then results for andN p 3,000 N p 6000 1
are most consistent with these two data sets considered
together. The demographic model cannot be taken lit-
erally, but these results suggest that there was a severe
reduction in population size during the period between
A.D. 1100 and 1400 and a less severe reduction in size
after A.D. 70. A severe bottleneck in A.D. 70 or additional
bottlenecks between A.D. 70 and 1348 would make a
founder effect in Ashkenazi Jews more likely and, hence,
would make it more difﬁcult for I1307K at APC not to
have undergone a founder effect in A.D. 70.
Other NLSDs
Several other NLSDs are caused by alleles found only
in AJ individuals. Table 4 shows results of the analysis
of data from ﬁve such alleles. All of these alleles are
present at lower frequencies than N370S and I1307K
and, hence, are easier to ﬁt with the founder-effect hy-
pothesis. The results in table 4 were generated using only
one demographic model, and ,N p 3,000 N p 6000 1
but results for other combinations were similar. Neu-
trality cannot be rejected, and the data are consistent
with a founder effect. Only for the allele in highest fre-
quency (at DYS) is a founder effect at A.D. 1348 rejected.
Allele Age and Allele Frequency
Although the results presented here support the main
conclusion of Risch et al. (2003) that founder effects are
sufﬁcient to account for AJ Mendelian diseases, they do
not support the more detailed conclusions concerning
the times at which the founder events took place. In fact,
they contradict the claim that the alleles with frequencies
11.5% (at GBA, APC, and DYS) could have reached
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Figure 3 Scatterplot of t2 (the coalescence time of all copies of A)
and jo (the number of nonrecombinants) generated in 1,000 replicate
forward simulations of a neutral allele thatwas in one copy t1 generations
in the past and was found at with a frequency between 0.027 andtp 0
0.037 (i.e., , which was chosen to match the fre-xp 0.032 0.005
quency of N370S at GBA, 0.032). In each replicate, the allele age (t1)
was chosen randomly from a probability distribution on t in which
is proportional to , where is based on table 1 withPr (t) N(t) N(t)
and . Parameters for A and the linked markerN p 600 N p 3,0000 1
are the same as for N370S at GBA: , , ,ip 268 j p 163 p p 0.205o N
and (cf. table 2).vp 0.007
Table 4
Analysis of Alleles Causing NLSDs
Locus Allele Marker Referencea x i jo pN v Pr(j j )o
Pr(m 1)
When t p 26F
Pr(m 1)
When t p 77.2F
BRCA1 185delAG D17S1320 Neuhausen et al. 1996 .01 15 15 .27 .005 .26 .15 .97
BLM blmAsh D15S1108 Ellis et al. 1998 .0047 52 43 .1b .00025 .98 .58 .97
DYS 20576TrCc D9S261 Blumenfeld et al. 1999 .0158 435 403 .53 .008 .33 .02 .93
ITY1 GAG deletiond ASS Risch et al. 1995b .0005 54 47 .09 .018 .07 .98 .99
LDLR G197del D19S865 Durst et al. 2001 .0074 37 26 .22 .026 .21 .22 .99
NOTE.—All results are based on 10,000 replicates with N0p3,000 and N1p600.
a References are to the articles from which the genetic parameters (x, i, jo, pN, and ) were extracted.v
b Ancestral marker allele frequency not available. Similar results were obtained for other values of pN.
c Causative allele was identiﬁed and named by Anderson et al. (2001).
d Causative allele was identiﬁed by Ozelius et al. (1997).
those frequencies because of a founder event 40–50 gen-
erations ago. Instead, those alleles probably originated
much earlier and were affected by the founder event in
A.D. 70. The reason for this difference is that the method
used here for estimating allele age takes explicit account
of allele frequency, whereas Risch et al. (2003) and the
studies cited therein use methods that estimate age only
from the pattern of LD with linked markers (jo in the
notation here) and not from the allele frequency.
To determine how much information about allele age
is given by jo alone, I performed a simple forward sim-
ulation. In each replicate, a neutral allele was introduced
in a single copy in a population with the history of
population sizes given in table 1 (with andN p 3,0000
). The time at which it was introduced (t1, theN p 6001
allele age) was chosen randomly from a distribution
proportional to , because the number of targets forN(t)
mutation at a locus each generation is twice the pop-
ulation size. The simulation generated the number of
copies in each generation between generations intp t1
the past and (the present) by use of a Wright-tp 0
Fisher model and retained the replicate if the frequency
at 0 was within a speciﬁed range. For each replicate
retained, a neutral coalescent process was run back-
wards to generate the intra-allelic genealogy of the i
copies of A in a sample. On that genealogy, a two-state
Markov chain was simulated, representing the transi-
tions from AM to Am chromosomes and the reverse,
given values of v and pM and under the assumption that
the ancestral A chromosome carried M at the marker
locus. Each such replicate resulted in a value of jo, the
observed number of AM chromosomes at , andtp 0
the value of t2, the time of the most recent common
ancestor of the intra-allelic genealogy. Figure 3 shows
the results of 1,000 replicates for parameter values cho-
sen to mimic the N370S allele at GBA (cf. table 2 and
ﬁg. 2).
It is clear from ﬁgure 3 that a given t2 is consistent
with a wide range of values of jo and that a given jo is
consistent with a wide range of values of t2. Similar
results were obtained in other cases. The reason there
is so much scatter is that a single recombination event
early in the intra-allelic genealogy can result in multiple
recombinant chromosomes, an effect similar to the well-
known jackpot effect in the Luria-Delbru¨ck model (Lu-
ria and Delbru¨ck 1943). Under these assumptions, the
correlation between jo and t2 is not strong enough for
jo alone to provide a reliable estimate of t2.
To illustrate how difﬁcult it is for a recent founder
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Figure 4 The probability that an allele present in one copy at
is still segregating and has a frequency of at least x 26.08 gen-tp 0
erations later. Calculations were made using the theory described in the
appendix.
event to result in an allele having a relatively high fre-
quency, I adapted Kimura’s (1955) model to allow for
variable population size. When this theory, which is
outlined in the appendix, is used, it is possible to com-
pute the probability that an allele that exists initially as
one copy in A.D. 1348 has a frequency y at least as large
as a speciﬁed frequency x. Figure 4 shows the results
for two different population sizes in A.D. 1348 (200 and
1,000, corresponding to census sizes of 600 and 3,000).
Even with , there is only a very low proba-N p 2001
bility (!0.02) that an allele carried by one of the 400
founder chromosomes could reach a frequency 10.015.
Discussion and Conclusions
The founder-effect hypothesis has two components: the
allele is neutral, and all copies are descended from a
copy that was either carried by one of the founding
individuals or arose later by mutation. The method in-
troduced here tests both parts of this hypothesis. The
tests are model-based, meaning that an explicit popu-
lation-genetic model is used. Any such model is only a
crude approximation of reality, but it is useful if it in-
corporates the most important features of the processes
considered and if the conclusions are robust to violations
of the underlying assumptions.
For the application to AJ Mendelian disease alleles,
the genetic assumptions are that chromosomes carrying
the nonancestral allele were generated by recombination
of A-bearing chromosomes with non-A chromosomes
and that the frequency of marker alleles on non-A chro-
mosomes did not change. The ﬁrst of these assumptions
requires that recombination between A-bearing chro-
mosomes is sufﬁciently infrequent that it can be ignored,
which is reasonable for the low-frequency disease-as-
sociated alleles considered here. The results are not sen-
sitive to deviations from the second assumption. Tem-
poral variation in the background marker frequencies
result in only minor changes in the results of the neu-
trality test (author’s unpublished simulations).
The demographic assumptions for the AJ population
are more problematic. Estimated population sizes after
A.D. 1500 are based on historical records, but, even so,
there are differences of opinion about how those records
are interpreted (Risch et al. 1995a; Zoossmann-Diskin
1995). Before 1500, the historical record is meager, and
only a broad outline of the history of populations an-
cestral to Ashkenazi Jews is known. The demographic
assumptions used here allow for a bottleneck in size in
A.D. 1348, after the expulsion of Jews from France and
Germany and after the Black Death. The actual date of
the bottleneck is not as important as the fact that the
effective size decreased dramatically after the peak in
size at A.D. ∼1100. Varying N1 allows investigation of
bottlenecks of varying severity.
Similarly, assuming a constant exponential growth
rate from a size N0 in A.D. 70 until ∼1100 is not realistic,
but it embodies the idea that there was a bottleneck
early in the Diaspora. If there were additional bottle-
necks, as seems likely, their effects are included in N0,
which indicates the overall potential for a founder effect
between A.D. 70 and 1100. Given the absence of more-
detailed historical records during this period, more-
elaborate demographic assumptions are not called for.
The model assumes no population subdivision and
thus ignores the fact that, until the 20th century, move-
ment among different parts of the AJ population must
have been restricted. Because the disease-associated al-
leles considered here are widespread in the AJ popu-
lation (Risch and Tang 2003), the problem is to explain
the overall allele frequency and extent of LDwith linked
markers, not patterns of variation among different AJ
subpopulations. When considering the populationwide
allele frequencies, population subdivision can be al-
lowed for by increasing the effective population size in
a coalescent model (Nordborg and Krone 2002).
Statistical Power of the Neutrality Test
Although neutrality is not rejected for the alleles con-
sidered here, the test is not expected to have much sta-
tistical power unless selection is very strong. The reason
is that, roughly speaking, the prior distribution of allele
age, on which the test depends, is a function primarily
of , where r is the population growth rate and s isr s
the selective advantage of heterozygous carriers (Slatkin
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2002). During the past 500 years, the AJ population has
grown at a rate of ∼40% per 25-year generation (rp
). Therefore, even selection thought to be strong—0.4
say, —will not affect the prior distribution of agesp 0.1
by much.
I determined the power of the neutrality test by using
the forward simulation described above and assuming
a selective advantage to heterozygous carriers of sp
. With parameters chosen to match I1307K at APC0.1
(see table 3), and with and , neu-N p 3,000 N p 6000 1
trality was rejected for only 28.4% of the replicates if
the allele was additive in its effect on ﬁtness. Assuming
heterozygote advantage makes little difference, because
the allele frequency is so small. If homozygous individ-
uals have a 20% lower ﬁtness than normal homozygotes
(i.e., 30% lower than heterozygotes), neutrality is re-
jected in 26.9% of the replicates.
The failure to reject neutrality for the alleles consid-
ered here does not provide strong evidence that they are
actually neutral. But selection is not needed to account
for their presence in the AJ population or the degree of
LD with linked markers. A founder effect is sufﬁcient.
Overrepresentation of LSDs
One of the strongest arguments in favor of hetero-
zygote advantage is that alleles causing four different
LSDs are found in relatively high frequency in the AJ
population, despite their deleterious effects on homo-
zygous individuals (Diamond 1994; Motulsky 1995).
The analysis performed here shows that founder effects
can account for the disease-associated alleles at GBA and
MLIV, but it does not answer the question of why those
loci and not others have alleles at relatively high fre-
quencies in the AJ population. I suggest that alleles at
the four LSD loci do not give a ﬁtness advantage to
heterozygous carriers, but they also do not reduce the
ﬁtness of carriers. Completely recessive alleles can in-
crease in frequency when rare because of genetic drift
alone. However, if those alleles are even slightly dele-
terious to heterozygotes, the chance of increasing in fre-
quency in a small population is greatly diminished. In
Drosophila, most mutations that are strongly deleterious
to homozygous individuals also are slightly deleterious
to heterozygotes (Crow 1979). If that is true in humans,
then we would expect many apparently recessive genetic
diseases to slightly decrease heterozygote ﬁtness. Those
that do not would be exceptional. If mutations atHEXA,
responsible for Tay-Sachs disease, are completely reces-
sive, that would help explain why Tay-Sachs has an el-
evated frequency in other isolated populations, including
French Canadians, Acadians of Louisiana, and other
populations (Risch 2001).
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Appendix
In a population of effective size at time t, theN(t)
probability distribution of the frequency x of an allele
is described approximately by the time-dependent dif-
fusion equation
2f(x,t) 1  [ ]p x(1 x)f(x,t) (A1)2t 4N(t) x
(Kimura 1955), where is the probability distri-f(x,t)
bution of x at t. Time can be rescaled by deﬁning
t
′dt
t(t)p (A2) ′2N(t )
0
(Grifﬁths and Tavare´ 1994), and equation (A1) can be
rewritten, in terms of t, as
2f(x,t) 1  [ ]p x(1 x)f(x,t) . (A3)2t 2 x
Kimura (1955) derived the complete solution to equa-
tion (A3) under the assumption that the frequency at 0
is p. The solution is an inﬁnite sum of products of hy-
pergeometric functions that is easy to evaluate using a
computer algebra program. For a given and a par-N(t)
ticular time of interest—say, t*—it is necessary only to
use equation (A2) to compute the corresponding t*.
To ﬁnd the probability that an allele initially present
in one copy at has a frequency x at t*, whichtp 0
is what is plotted in ﬁgure 4, the integral is1 f(y,t∗)dy∫x
needed. It was much more efﬁcient computationally to
integrate each term in the series analytically and then
compute the sum than it was to numerically integrate
the series itself. The results plotted in ﬁgure 4 also ac-
count for the fact that the allele considered is still seg-
regating at t*. In the model of the AJ population with
(A.D. 1348), and∗ ∗t p 26.04 t p 0.00477 pp
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for , and and∗0.0025 N p 200 t p 0.00175 pp1
for .0.0005 N p 3,0001
Electronic-Database Information
The URLs for data presented herein are as follows:
Online Mendelian Inheritance in Man (OMIM), http://www
.ncbi.nlm.nih.gov/Omim/ (for type I Gaucher disease,MLIV,
and APC)
Slatkin Laboratory Genetics Software, http://ib.berkeley.edu/
labs/slatkin/software.html
TSC SNP Linkage Map, http://compgen.rutgers.edu/SNPmap/
UCSC Human Genome Browser, http://genome.ucsc.edu/
cgi-bin/hgGateway
References
Anderson SL, Coli R, Daly IW, Kichula EA, Rork MJ, Volpi
SA, Ekstein J, Rubin BY (2001) Familial dysautonomia is
caused by mutations of the IKAP gene. Am J Hum Genet
68:753–758
Bargal R, AvidanN, Ben-Asher E, Olender Z, ZeiglerM, Frum-
kin A, Raas-Rothschild A, Glusman G, Lancet D, Bach G
(2000) Identiﬁcation of the gene causing mucolipidosis type
IV. Nat Genet 26:118–123
Barnavi E (ed) (1992) A historical atlas of the Jewish people:
from the time of the Patriarchs to the present. Knopf, New
York
Beutler E, Nguyen NJ, Henneberger MW, Smolec JM, Mc-
Pherson RA, West C, Gelbart T (1993) Gaucher disease:
gene frequencies in the Ashkenazi Jewish population. Am J
Hum Genet 52:85–88
Blumenfeld A, Slaugenhaupt SA, Liebert CB, Temper V,
Maayan C, Gill S, Lucente DE, Idelson M, MacCormack K,
Monahan MA, Mull J, Leyne M, Mendillo M, Schiripo T,
Mishori E, Breakeﬁeld X, Axelrod FB, Gusella JF (1999)
Precise genetic mapping and haplotype analysis of the fa-
milial dysautonomia gene on human chromosome 9q31. Am
J Hum Genet 64:1110–1118
Colombo R (2000) Age estimate of the N370S mutation caus-
ing Gaucher disease in Ashkenazi Jews and European pop-
ulations: a reappraisal of haplotype data. Am J Hum Genet
66:692–697
Crow JF (1979) Minor viability mutants in Drosophila. Ge-
netics 92:s165–s172
Diamond JM (1994) Human genetics: Jewish lysosomes. Na-
ture 368:291–292
Diaz GA, Gelb BD, Risch N, Nygaard TG, Frisch A, Cohen
IJ, Miranda CS, Amaral O, Maire I, Poenaru L, Caillaud C,
Weizberg M, Mistry P, Desnick RJ (2000) Gaucher disease:
the origins of the Ashkenazi Jewish N370S and 84GG acid
b-glucosidase mutations. Am J Hum Genet 66:1821–1832
Durst R, Colombo R, Shpitzen S, Avi LB, Friedlander Y,Wexler
R, Raal FJ, Marais DA, Defesche JC, Mandelshtam MY,
Kotze MJ, Leitersdorf E, Meiner V (2001) Recent origin and
spread of a common Lithuanian mutation, G197del LDLR,
causing familial hypercholesterolemia: positive selection is
not always necessary to account for disease incidence among
Ashkenazi Jews. Am J Hum Genet 68:1172–1188
Ellis NA, Ciocci S, Proytcheva M, Lennon D, Groden J,
German J (1998) The Ashkenazic Jewish Bloom syndrome
mutation blmAsh is present in non-Jewish Americans of Span-
ish ancestry. Am J Hum Genet 63:1685–1693
Engleman UZ (1960) Sources of Jewish statistics. In: Finkel-
stein J (ed) The Jews: their history, culture and religion. Vol
2. Harper, New York, pp 1172–1197
Fraikor AL (1977) Tay-Sachs disease: genetic drift among the
Ashkenazim Jews. Soc Biol 24:117–134
Frisch A, Colombo R, Michaelovsky E, Karpati M, Goldman
B, Peleg L (2004) Origin and spread of the 1278insTATC
mutation causing Tay-Sachs disease in Ashkenazi Jews: ge-
netic drift as a robust and parsimonious hypothesis. Hum
Genet 114:366–376
Goldstein DB, Reich DE, Bradman N, Usher S, Seligsohn U,
Peretz H (1999) Age estimates of two common mutations
causing factor XI deﬁciency: recent genetic drift is not nec-
essary for elevated disease incidence among Ashkenazi Jews.
Am J Hum Genet 64:1071–1075
Grifﬁths RC, Tavare´ S (1994) Sampling theory for neutral
alleles in a varying environment. Philos Trans R Soc Lond
B Biol Sci 344:403–410
Hill WG (1972) Effective size of populations with overlapping
generations. Theor Popul Biol 3:278–289
Kimura M (1955) Solution of a process of random genetic
drift with a continuous model. Proc Natl Acad Sci USA 41:
144–150
Lewontin RC (1964) The interaction of selection and linkage.
I. General considerations; heterotic models. Genetics 49:49–
67
Luria SE, Delbru¨ck M (1943) Mutations of bacteria from virus
sensitivity to virus resistance. Genetics 28:491–511
Matise TC, Sachidanandam R, Clark AG, Kruglyak L, Wijs-
man E, Kakol J, Buyske S, et al (2003) A 3.9-centimorgan-
resolution human single-nucleotide polymorphism linkage
map and screening set. Am J Hum Genet 73:271–284
Motulsky AG (1979) Possible selective effects of urbanization
on Ashkenazi Jews. In: Goodman RM, Motulsky AG (eds)
Genetic diseases among Ashkenazi Jews. Raven Press, New
York, pp 301–314
——— (1995) Jewish diseases and origins. Nat Genet 9:99–
101
Mourant AE, Kopec AC, Domaniewska-Sobczak K (1978) The
genetics of Jews. Clarendon Press, Oxford
Neuhausen SL, Mazoyer S, Friedman L, Stratton M, Ofﬁt K,
Caligo A, Tomlinson G, Cannon-Albright L, Bishop T, Kel-
sell D, Solomon E, Weber B, Couch F, Struewing J, Tonin
P, Durocher F, Narod S, Skolnick MH, Lenoir G, Serova O,
Ponder B, Stoppa-Lyonnet D, Easton D, King MC, Goldgar
DE (1996) Haplotype and phenotype analysis of six recur-
rent BRCA1 mutations in 61 families: results of an inter-
national study. Am J Hum Genet 58:271–280
Niell BL, Long JC, Rennert G, Gruber SB (2003) Genetic an-
thropology of the colorectal cancer-susceptibility allele APC
I1307K: evidence of genetic drift within the Ashkenazim.
Am J Hum Genet 73:1250–1260
Nordborg M, Krone SM (2002) Separation of time scales and
convergence to the coalescent in structured populations. In:
Slatkin M, Veuille M (eds) Modern developments in theo-
retical population genetics. Oxford University Press, New
York, pp 194–232
Ozelius LJ, Hewett JW, Page CE, Bressman SB, Kramer PL,
Slatkin: Test of the Founder-Effect Hypothesis 293
Shalish C, De Leon D, Brin MF, Raymond D, Corey DP,
Fahn S, Risch NJ, Buckler AJ, Gusella JF, Breakeﬁeld XO
(1997) The early-onset torsion dystonia gene (DYT1) en-
codes an ATP-binding protein. Nat Genet 17:40–48
Risch N (2001) Molecular epidemiology of Tay-Sachs disease.
Adv Genet 44:233–252
Risch N, de Leon D, Fahn S, Bressman S, Ozelius L, Breakeﬁeld
X, Kramer P, Almasy L, Singer B (1995a) ITD in Ashkenazi
Jews—genetic drift or selection?: in reply. Nat Genet 11:14–
15
Risch N, de Leon D, Ozelius L, Kramer P, Almasy L, Singer
B, Fahn S, Breakeﬁeld X, Bressman S (1995b) Genetic anal-
ysis of idiopathic torsion dystonia in Ashkenazi Jews and
their recent descent from a small founder population. Nat
Genet 9:152–159
Risch N, Tang H (2003) Selection in the Ashkenazi Jewish
population unlikely—reply to Zlotogora and Bach. Am J
Hum Genet 73:440–441
Risch N, Tang H, Katzenstein H, Ekstein J (2003) Geographic
distribution of disease mutations in the Ashkenazi Jewish
population supports genetic drift over selection. Am J Hum
Genet 72:812–822
Rotter JI, Diamond JM (1987) What maintains the frequencies
of human genetic diseases? Nature 329:289–290
Slatkin M (2002) The age of alleles. In: Slatkin M, Veuille M
(eds) Modern developments in theoretical population ge-
netics. Oxford University Press, Oxford, pp 233–259
Slatkin M, Bertorelle G (2001) The use of intra-allelic varia-
bility for testing neutrality and estimating population
growth rate. Genetics 158:865–874
Slaugenhaupt SA, Acierno JS Jr, Helbling LA, Bove C, Goldin
E, Bach G, Schiffmann R, Gusella JF (1999) Mapping of
the mucolipidosis type IV gene to chromosome 19p and
deﬁnition of founder haplotypes. Am J Hum Genet 65:773–
778
Thompson EA, Neel JV (1996) Private polymorphisms: how
many? how old? how useful for genetic taxonomies? Mol
Phylogenet Evol 5:220–231
——— (1997) Allelic disequilibrium and allele frequency dis-
tribution as a function of social and demographic history.
Am J Hum Genet 60:197–204
Vogel F, Motulsky AG (1996) Human genetics: problems and
approaches. Springer-Verlag, New York
Weinryb BD (1972) The Jews of Poland: a social and economic
history of the Jewish community in Poland from 1100 to
1800. Jewish Publication Society of America, Philadelphia
Zlotogora J, Zeigler M, Bach G (1988) Selection in favor of
lysosomal storage disorders? Am J Hum Genet 42:271–273
Zoossmann-Diskin A (1995) ITD in Ashkenazi Jews—genetic
drift or selection? Nat Genet 11:13–15
